arrow_back Trending Legislation
Share share

Designating National Leiomyosarcoma Awareness Day

The U.S. Senate designated July 15, 2023, as National Leiomyosarcoma Awareness Day. This resolution aims to highlight this rare and aggressive cancer, which affects all ages and is largely resistant to current standard treatments. The designation encourages greater public education and recognition of the challenges faced by patients and the dedication of researchers.
Key points
July 15th is officially designated to raise awareness about leiomyosarcoma, a rare and difficult-to-treat cancer.
The resolution formally recognizes the struggles of patients and commends the efforts of caregivers and researchers working on this disease.
Increased public awareness is intended to support better research outcomes and improve the quality of life for those affected.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A resolution designating July 15, 2023, as "National Leiomyosarcoma Awareness Day".
Print number: SRES 270
Sponsor: Sen. Stabenow, Debbie [D-MI]
Process start date: 2023-06-22
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Designating National Leiomyosarcoma Awareness Day

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is SRES 270.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-06-22.

What are the main provisions?

Key points include:

  • July 15th is officially designated to raise awareness about leiomyosarcoma, a rare and difficult-to-treat cancer.
  • The resolution formally recognizes the struggles of patients and commends the efforts of caregivers and researchers working on this disease.
  • Increased public awareness is intended to support better research outcomes and improve the quality of life for those affected.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Stabenow, Debbie [D-MI].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of SRES 270

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health